Our Mission
We strive to make prostate cancer diagnosis quicker, more affordable, and less invasive by pairing artificial intelligence technology with ultrasound imaging.
Executive Management Team
Mark Bloemendaal
CEO
Prof. Dr. ir. Massimo Mischi
Scientific Strategic Advisor
Prof. Dr. ir. Hessel Wijkstra
Clinical Strategic Advisor
Prof. Dr. Harrie Beerlage
Clinical Board Chairman
Clinical Board
Prof. Dr. Hashim Ahmed
Board Member
Prof. Dr. Chris Bangma
Board Member
Prof. Dr. Harrie Beerlage
Chairman
Prof. Dr. Alberto Briganti
Board Member
Prof. Dr. Daniel Eberli
Board Member
Prof. Dr. Jurgen Fütterer
Board Member
Prof. Dr. Peter Pinto
Board Member
Prof. Dr. Hendrick van Poppel
Board Member
Prof. Dr. Georg Salomon
Board Member
Prof. Dr. Jochen Walz
Board Member